Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

被引：45
|
作者：
Prebet, Thomas [1 ,2 ,3 ]
Gore, Steven D. [1 ,3 ]
Thepot, Sylvain [3 ]
Esterni, Benjamin [2 ]
Quesnel, Bruno [3 ]
Rauzy, Odile Beyne [3 ]
Dreyfus, Francois [3 ]
Gardin, Claude [3 ]
Fenaux, Pierre [3 ]
Vey, Norbert [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Hematol Malignancies, Baltimore, MD 21218 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Grp Francophone Myelodysplasies, Bobigny, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 06期
关键词：
Myelodysplasia; acute myeloid leukaemia; azacitidine; relapse; outcome; CONVENTIONAL CARE REGIMENS;
D O I：
10.1111/j.1365-2141.2012.09076.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [1] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Lesley J. Scott
    Drugs, 2016, 76 : 889 - 900
  • [2] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Scott, Lesley J.
    DRUGS, 2016, 76 (08) : 889 - 900
  • [3] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [4] Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine
    Duong, Vu H.
    Bhatnagar, Bhavana
    Zandberg, Dan P.
    Vannorsdall, Emily J.
    Tidwell, Michael L.
    Chen, Qing
    Baer, Maria R.
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1718 - 1722
  • [5] Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Furstoss, Nathan
    Savy, Coline
    El Manaa, Wejdane
    Zerhouni, Marwa
    Blot, Lauriane
    Calleja, Anne
    Dufies, Maeva
    Dubois, Alix
    Ginet, Clemence
    Mounier, Nicolas
    Garnier, Georges
    Raynaud, Sophie
    Rohrlich, Pierre Simon
    Peterlin, Pierre
    Stamatoullas, Aspasia
    Chermat, Fatiha
    Fenaux, Pierre
    Jacquel, Arnaud
    Robert, Guillaume
    Auberger, Patrick
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [6] Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients
    Petit, C.
    Saillard, C.
    Mohty, B.
    Hicheri, Y.
    Villetard, F.
    Maisano, V.
    Charbonnier, A.
    Rey, J.
    D'Incan, E.
    Rouzaud, C.
    Gelsi-Boyer, V.
    Murati, A.
    Lhoumeau, A. C.
    Ittel, A.
    Mozziconacci, M. J.
    Alary, A. S.
    Hospital, M. -A.
    Vey, N.
    Garciaz, S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 530 - 537
  • [7] Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine
    Laufer, Christin B.
    Roberts, Owen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (05) : 484 - 485
  • [8] Azacitidine A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia
    Keating, Gillian M.
    DRUGS, 2012, 72 (08) : 1111 - 1136
  • [9] Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
    van der Helm, Lieke H.
    Alhan, Canan
    Wijermans, Pierre W.
    Kooy, Marinus van Marwijk
    Schaafsma, Ron
    Biemond, Bart J.
    Beeker, Aart
    Hoogendoorn, Mels
    van Rees, Bastiaan P.
    de Weerdt, Okke
    Wegman, Jurgen
    Libourel, Ward J.
    Luykx-de Bakker, Sylvia A.
    Minnema, Monique C.
    Brouwer, Rolf E.
    Boer, Fransien Croon-de
    Eefting, Matthijs
    Jie, Kon-Siong G.
    de Loosdrecht, Arjan A. van
    Koedam, Jan
    Veeger, Nic J. G. M.
    Vellenga, Edo
    Huls, Gerwin
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (05) : 599 - 606
  • [10] Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
    Rautenberg, Christina
    Bergmann, Anika
    Germing, Ulrich
    Fischermanns, Caroline
    Pechtel, Sabrina
    Kaivers, Jennifer
    Jager, Paul
    Schuler, Esther
    Haas, Rainer
    Kobbe, Guido
    Schroeder, Thomas
    CANCERS, 2020, 12 (08) : 1 - 15
12345